Mouse Tnip1 Conditional Knockout Project (CRISPR/Cas9)

Total Page:16

File Type:pdf, Size:1020Kb

Load more

https://www.alphaknockout.com Mouse Tnip1 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Tnip1 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Tnip1 gene (NCBI Reference Sequence: NM_001199275 ; Ensembl: ENSMUSG00000020400 ) is located on Mouse chromosome 11. 19 exons are identified, with the ATG start codon in exon 3 and the TGA stop codon in exon 19 (Transcript: ENSMUST00000102731). Exon 5~6 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Tnip1 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-357E11 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for a null allele exhibit perinatal lethality associated with anemia and focal apoptosis in the fetal liver. Mice homozygous for a gene trap allele exhibit partial prenatal lethality and SLE-like inflammatory disease. Exon 5 starts from about 14.17% of the coding region. The knockout of Exon 5~6 will result in frameshift of the gene. The size of intron 4 for 5'-loxP site insertion: 1532 bp, and the size of intron 6 for 3'-loxP site insertion: 2280 bp. The size of effective cKO region: ~2504 bp. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 4 5 6 19 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Tnip1 Homology arm cKO region loxP site Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(8605bp) | A(21.84% 1879) | C(25.85% 2224) | T(25.57% 2200) | G(26.75% 2302) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 8 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr11 - 54938316 54941315 3000 browser details YourSeq 138 2442 2606 3000 97.4% chr2 + 102209051 102209217 167 browser details YourSeq 136 2458 2607 3000 96.7% chr2 - 11525582 11572650 47069 browser details YourSeq 130 2442 2607 3000 90.5% chr18 - 60841279 60841440 162 browser details YourSeq 129 2443 2607 3000 94.5% chr2 - 151003187 151003540 354 browser details YourSeq 129 2445 2607 3000 91.2% chrX + 61911690 61911847 158 browser details YourSeq 128 2442 2607 3000 88.0% chr5 - 136390113 136390256 144 browser details YourSeq 127 2448 2607 3000 86.9% chr14 + 15915088 15915233 146 browser details YourSeq 126 2470 2618 3000 96.4% chr2 + 104747573 104747970 398 browser details YourSeq 126 2460 2607 3000 95.2% chr18 + 13993359 13993519 161 browser details YourSeq 125 2460 2607 3000 93.0% chr6 + 3997068 3997214 147 browser details YourSeq 123 2040 2607 3000 81.0% chr12 - 70139784 70139961 178 browser details YourSeq 123 2445 2606 3000 86.5% chr6 + 18854389 18854530 142 browser details YourSeq 121 2442 2594 3000 88.3% chr5 - 55475438 55475574 137 browser details YourSeq 120 2460 2606 3000 93.1% chr1 - 110354696 110354847 152 browser details YourSeq 119 2414 2599 3000 96.1% chr9 - 20896596 20896843 248 browser details YourSeq 119 2471 2607 3000 95.5% chr15 - 8053780 8053926 147 browser details YourSeq 116 2452 2597 3000 95.4% chr7 - 63487269 63487603 335 browser details YourSeq 116 2457 2607 3000 87.0% chr2 - 31870189 31870318 130 browser details YourSeq 115 2479 2607 3000 96.8% chr1 + 156508947 156509080 134 Note: The 3000 bp section upstream of Exon 5 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr11 - 54933211 54936210 3000 browser details YourSeq 207 2530 2963 3000 95.3% chr7 + 122935966 122936623 658 browser details YourSeq 197 2515 2966 3000 92.0% chr5 - 67852052 67852627 576 browser details YourSeq 195 2698 2969 3000 94.5% chrX + 103974512 103975145 634 browser details YourSeq 193 2646 2970 3000 95.3% chr15 - 102311037 102311704 668 browser details YourSeq 192 2551 2966 3000 95.7% chr10 - 121478433 121479069 637 browser details YourSeq 184 2596 2969 3000 88.4% chr8 - 110484612 110484906 295 browser details YourSeq 183 2714 2969 3000 96.5% chr6 - 88475168 88475591 424 browser details YourSeq 183 2764 2972 3000 97.0% chr2 - 144765896 144766111 216 browser details YourSeq 183 2773 2976 3000 95.5% chr3 + 95592563 95592774 212 browser details YourSeq 183 2766 2969 3000 93.5% chr12 + 4084866 4085066 201 browser details YourSeq 181 2765 2969 3000 94.5% chr9 - 95794713 95794916 204 browser details YourSeq 181 2774 2969 3000 94.3% chr11 + 115504479 115504670 192 browser details YourSeq 179 2767 2969 3000 95.9% chr14 - 55696286 55696489 204 browser details YourSeq 179 2774 2970 3000 93.3% chr3 + 30622436 30622628 193 browser details YourSeq 179 2780 2969 3000 97.4% chr13 + 66989444 66989635 192 browser details YourSeq 178 2767 2970 3000 96.4% chr10 - 128260329 128260539 211 browser details YourSeq 178 2765 2970 3000 95.5% chr5 + 108047753 108047998 246 browser details YourSeq 177 2779 2969 3000 94.7% chr4 - 33211536 33211723 188 browser details YourSeq 177 2768 2968 3000 95.4% chr11 - 103965861 103966063 203 Note: The 3000 bp section downstream of Exon 6 is BLAT searched against the genome. No significant similarity is found. Page 4 of 8 https://www.alphaknockout.com Gene and protein information: Tnip1 TNFAIP3 interacting protein 1 [ Mus musculus (house mouse) ] Gene ID: 57783, updated on 12-Aug-2019 Gene summary Official Symbol Tnip1 provided by MGI Official Full Name TNFAIP3 interacting protein 1 provided by MGI Primary source MGI:MGI:1926194 See related Ensembl:ENSMUSG00000020400 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as Nef; VAN; ABIN; Naf1; ABIN1; ABIN-1; AU018810 Expression Ubiquitous expression in colon adult (RPKM 26.8), duodenum adult (RPKM 23.7) and 28 other tissues See more Orthologs human all Genomic context Location: 11; 11 B1.3 See Tnip1 in Genome Data Viewer Exon count: 20 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 11 NC_000077.6 (54910787..54962956, complement) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 11 NC_000077.5 (54724289..54776440, complement) Chromosome 11 - NC_000077.6 Page 5 of 8 https://www.alphaknockout.com Transcript information: This gene has 12 transcripts Gene: Tnip1 ENSMUSG00000020400 Description TNFAIP3 interacting protein 1 [Source:MGI Symbol;Acc:MGI:1926194] Gene Synonyms A20-binding inhibitor of NF-kappa B activation, ABIN1, Nef, VAN Location Chromosome 11: 54,910,785-54,962,917 reverse strand. GRCm38:CM001004.2 About this gene This gene has 12 transcripts (splice variants), 200 orthologues, 2 paralogues, is a member of 1 Ensembl protein family and is associated with 68 phenotypes. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Tnip1-203 ENSMUST00000102731.7 2973 647aa ENSMUSP00000099792.1 Protein coding CCDS24704 E9QM75 TSL:5 GENCODE basic APPRIS P3 Tnip1-206 ENSMUST00000108889.9 2834 647aa ENSMUSP00000104517.3 Protein coding CCDS24704 E9QM75 TSL:1 GENCODE basic APPRIS P3 Tnip1-201 ENSMUST00000018482.12 2810 647aa ENSMUSP00000018482.6 Protein coding CCDS24704 E9QM75 TSL:1 GENCODE basic APPRIS P3 Tnip1-202 ENSMUST00000102730.8 2787 646aa ENSMUSP00000099791.2 Protein coding CCDS70188 D3Z2W0 TSL:1 GENCODE basic APPRIS ALT2 Tnip1-204 ENSMUST00000108885.7 2686 594aa ENSMUSP00000104513.1 Protein coding CCDS56769 Q9WUU8 TSL:1 GENCODE basic APPRIS ALT2 Tnip1-205 ENSMUST00000108886.7 2642 594aa ENSMUSP00000104514.1 Protein coding CCDS56769 Q9WUU8 TSL:1 GENCODE basic APPRIS ALT2 Tnip1-208 ENSMUST00000126703.7 941 272aa ENSMUSP00000122836.1 Protein coding - D3Z3B6 CDS 3' incomplete TSL:5 Tnip1-212 ENSMUST00000155316.1 878 214aa ENSMUSP00000116721.1 Protein coding - D3Z410 CDS 3' incomplete TSL:5 Tnip1-209 ENSMUST00000132224.1 442 No protein - Retained intron - - TSL:3 Tnip1-207 ENSMUST00000124304.1 1786 No protein - lncRNA - - TSL:1 Tnip1-211 ENSMUST00000151736.1 391 No protein - lncRNA - - TSL:2 Tnip1-210 ENSMUST00000132776.1 347 No protein - lncRNA - - TSL:3 Page 6 of 8 https://www.alphaknockout.com 72.13 kb Forward strand Genes Gpx3-202 >protein coding Gm12230-201 >processed pseudogene (Comprehensive set... Gpx3-201 >protein coding Gpx3-203 >protein coding Contigs AL593846.15 > Genes (Comprehensive set... < Tnip1-206protein coding
Recommended publications
  • Acute Lymphoblastic Leukemia Patient with Variant ATF7IP

    Acute Lymphoblastic Leukemia Patient with Variant ATF7IP

    ISSN 1941-5923 © Am J Case Rep, 2017; 18: 1204-1208 DOI: 10.12659/AJCR.906300 Received: 2017.07.20 Accepted: 2017.08.07 Acute Lymphoblastic Leukemia Patient with Published: 2017.11.14 Variant ATF7IP/PDGFRB Fusion and Favorable Response to Tyrosine Kinase Inhibitor Treatment: A Case Report Authors’ Contribution: BCDF 1,2 Ge Zhang* 1 Department of Pediatrics, Key Laboratory of Birth Defects and Related Diseases Study Design A BCD 1 Yanle Zhang* of Women and Children, Ministry of Health, West China Second University Data Collection B Hospital, Sichuan University, Chengdu, Sichuan, P.R. China Statistical Analysis C BD 1 Jianrong Wu 2 Department of Laboratory Medicine, West China Second University Hospital, Data Interpretation D AE 3 Yan Chen Sichuan University, Chengdu, Sichuan, P.R. China Manuscript Preparation E AE 1 Zhigui Ma 3 Department of Pediatrics, Affiliated Hospital of Zunyi Medical College, Zunyi, Literature Search F Guizhou, P.R. China Funds Collection G * Ge Zhang and Yanle Zhang contributed equally to this work Corresponding Authors: Zhigui Ma, e-mail: [email protected]; Yan Chen, e-mail: [email protected] Conflict of interest: None declared Patient: Female, 14-month-old Final Diagnosis: Acute lymphoblastic leukemia Symptoms: Fever Medication: — Clinical Procedure: — Specialty: Hematology Objective: Rare disease Background: Chromosomal translocations involving the PDGFRB gene have been reported in a broad spectrum of hemato- logical malignancies. An ATF7IP/PDGFRB fusion was recently identified in a Philadelphia chromosome-like (Ph- like) B-progenitor acute lymphoblastic leukemia (B-ALL) patient. Here we report on a special case of a Ph-like ALL patient who had a variant ATF7IP/PDGFRB fusion.
  • Laboratory Mouse Models for the Human Genome-Wide Associations

    Laboratory Mouse Models for the Human Genome-Wide Associations

    Laboratory Mouse Models for the Human Genome-Wide Associations The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Kitsios, Georgios D., Navdeep Tangri, Peter J. Castaldi, and John P. A. Ioannidis. 2010. Laboratory mouse models for the human genome-wide associations. PLoS ONE 5(11): e13782. Published Version doi:10.1371/journal.pone.0013782 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:8592157 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Laboratory Mouse Models for the Human Genome-Wide Associations Georgios D. Kitsios1,4, Navdeep Tangri1,6, Peter J. Castaldi1,2,4,5, John P. A. Ioannidis1,2,3,4,5,7,8* 1 Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, United States of America, 2 Tufts University School of Medicine, Boston, Massachusetts, United States of America, 3 Department of Hygiene and Epidemiology, University of Ioannina School of Medicine and Biomedical Research Institute, Foundation for Research and Technology-Hellas, Ioannina, Greece, 4 Tufts Clinical and Translational Science Institute, Tufts Medical Center, Boston, Massachusetts, United States of America, 5 Department of Medicine, Center for Genetic Epidemiology and Modeling, Tufts Medical Center, Tufts University
  • Modulation of NF-Κb Signalling by Microbial Pathogens

    Modulation of NF-Κb Signalling by Microbial Pathogens

    REVIEWS Modulation of NF‑κB signalling by microbial pathogens Masmudur M. Rahman and Grant McFadden Abstract | The nuclear factor-κB (NF‑κB) family of transcription factors plays a central part in the host response to infection by microbial pathogens, by orchestrating the innate and acquired host immune responses. The NF‑κB proteins are activated by diverse signalling pathways that originate from many different cellular receptors and sensors. Many successful pathogens have acquired sophisticated mechanisms to regulate the NF‑κB signalling pathways by deploying subversive proteins or hijacking the host signalling molecules. Here, we describe the mechanisms by which viruses and bacteria micromanage the host NF‑κB signalling circuitry to favour the continued survival of the pathogen. The nuclear factor-κB (NF-κB) family of transcription Signalling targets upstream of NF‑κB factors regulates the expression of hundreds of genes that NF-κB proteins are tightly regulated in both the cyto- are associated with diverse cellular processes, such as pro- plasm and the nucleus6. Under normal physiological liferation, differentiation and death, as well as innate and conditions, NF‑κB complexes remain inactive in the adaptive immune responses. The mammalian NF‑κB cytoplasm through a direct interaction with proteins proteins are members of the Rel domain-containing pro- of the inhibitor of NF-κB (IκB) family, including IκBα, tein family: RELA (also known as p65), RELB, c‑REL, IκBβ and IκBε (also known as NF-κBIα, NF-κBIβ and the NF-κB p105 subunit (also known as NF‑κB1; which NF-κBIε, respectively); IκB proteins mask the nuclear is cleaved into the p50 subunit) and the NF-κB p100 localization domains in the NF‑κB complex, thus subunit (also known as NF‑κB2; which is cleaved into retaining the transcription complex in the cytoplasm.
  • Biological and Prognostic Significance of Chromosome 5Q Deletions in Myeloid Malignancies Aristoteles A.N

    Biological and Prognostic Significance of Chromosome 5Q Deletions in Myeloid Malignancies Aristoteles A.N

    Review Biological and Prognostic Significance of Chromosome 5q Deletions in Myeloid Malignancies Aristoteles A.N. Giagounidis,1Ulrich Germing,2 and Carlo Aul1 Abstract The presence of del(5q), either as the sole karyotypic abnormality or as part of a more complex karyotype, has distinct clinical implications for myelodysplastic syndromes (MDS) and acute myeloid leukemia. The 5qÀ syndrome, a subtype of low-riskMDS, is characterized by an isolated 5q deletion and <5% blasts in the bone marrow and can serve as a useful model for studying the role of 5q deletions in the pathogenesis and prognosis of myeloid malignancies. Recent clinical results with lenalidomide, an oral immunomodulatory drug, have shown durable erythroid responses, including transfusion independence and complete cytogenetic remissions in patients with del(5q) MDS with or without additional chromosomal abnormalities. These results indicate that lenalidomide can overcome the pathogenic effect of 5q deletion in MDS and restore bone marrow balance. The data provide important new insights into the pathobiology of 5q chromo- somal deletions in myeloid malignancies. Cytogenetic abnormalities are detected in the bone marrow of preponderance, refractory macrocytic anemia, normal or high over 50% of patients diagnosed with primary myelodysplastic platelet counts, hypolobulated megakaryocytes, and modest syndromes (MDS) or myeloid leukemias, and up to 80% of leukopenia (11, 14, 17). The prognosis is favorable in 5qÀ patients with secondary or therapy-related MDS (1, 2). These syndrome with relatively low risk of transformation to AML abnormalities can be characterized as being balanced or (11, 18). Although the limits of 5q deletions vary among unbalanced (3, 4). Balanced cytogenetic abnormalities include patients with 5qÀ syndrome, the most frequent deletion is reciprocal translocations, inversions, and insertions (3, 5, 6).
  • Confirmation of TNIP1 and IL23A As Susceptibility Loci for Psoriatic Arthritis

    Confirmation of TNIP1 and IL23A As Susceptibility Loci for Psoriatic Arthritis

    Concise report Ann Rheum Dis: first published as 10.1136/ard.2011.150102 on 29 May 2011. Downloaded from Confi rmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis John Bowes, 1 Gisela Orozco, 1 Edward Flynn, 1 Pauline Ho, 1,2 Rasha Brier, 1 Helena Marzo-Ortega, 3 Laura Coates,3 Ross McManus, 4 Anthony W Ryan, 4 David Kane, 5 Eleanor Korendowych, 6 Neil McHugh,6 Oliver FitzGerald, 7 Jonathan Packham, 8,9 Ann W Morgan, 3 Ian N Bruce, 1,2 Anne Barton 1,2 ▶ Additional data ABSTRACT different aetiologies, some differences in suscep- (supplementary tables) are Objectives To investigate a shared genetic aetiology for tibility loci would be expected. The identifi cation published online only. To view skin involvement in psoriasis and psoriatic arthritis (PsA) of risk loci specifi c to psoriasis would provide these fi les please visit the journal online at http://ard.bmj.com. by genotyping single-nucleotide polymorphisms (SNPs), compelling evidence that the genetic basis of the reported to be associated in genome-wide association skin component of the two diseases was differ- 1 Arthritis Research UK Epidemiology Unit, Manchester studies of psoriasis, in patients with PsA. ent. There has been some evidence reported to Academic Health Science Methods SNPs with reported evidence for association support this possibility. Variants within the LCE Centre, The University of with psoriasis were genotyped in a PsA case and control gene locus were reported to be associated with Manchester, Manchester, UK collection from the UK and Ireland. Genotype and allele psoriasis but not PsA in a German cohort, 10 but a 2 The Kellgren Centre for Rheumatology, Central frequencies were compared between PsA cases and subsequent study in a population from the British Manchester Foundation controls using the Armitage test for trend.
  • Confirmation of TNIP1 but Not RHOB and PSORS1C1 As Systemic Sclerosis Risk Factors in a Large Independent Replication Study

    Confirmation of TNIP1 but Not RHOB and PSORS1C1 As Systemic Sclerosis Risk Factors in a Large Independent Replication Study

    Downloaded from ard.bmj.com on August 13, 2013 - Published by group.bmj.com Basic and translational research EXTENDED REPORT Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study Lara Bossini-Castillo,1 Jose Ezequiel Martin,1 Jasper Broen,2 Carmen P Simeon,3 Lorenzo Beretta,4 Olga Y Gorlova,5 Madelon C Vonk,2 Norberto Ortego-Centeno,6 Gerard Espinosa,7 Patricia Carreira,8 Paloma García de la Peña,9 Natividad Oreiro,10 José Andrés Román-Ivorra,11 María Jesús Castillo,12 Miguel A González-Gay,13 Luis Sáez-Comet,14 Ivan Castellví,15 Annemie J Schuerwegh,16 Alexandre E Voskuyl,17 Anna-Maria Hoffmann-Vold,18 Roger Hesselstrand,19 Annika Nordin,20 Claudio Lunardi,21 Raffaella Scorza,4 Jacob M van Laar,22 Paul G Shiels,23 Ariane Herrick,24 Jane Worthington,24 Carmen Fonseca,25 Christopher Denton,25 Filemon K Tan,26 Frank C Arnett,26 Shervin Assassi,26 Bobby P Koeleman,27 Maureen D Mayes,26 Timothy R D J Radstake,2,28 Javier Martin,1 the Spanish Scleroderma Group* ▸ Additional supplementary ABSTRACT different internal organs.1 The contribution of data are published online only. Introduction A recent genome-wide association study fi different genetic factors to the development and To view these les please visit fi 2 the journal online (http://dx.doi. in European systemic sclerosis (SSc) patients identi ed prognosis of the disease is now widely accepted. org/10.1136/annrheumdis- three loci (PSORS1C1, TNIP1 and RHOB)asnovel Over the past few years, genome-wide association 2012-201888.bmj.com).
  • Recombinant Human TNIP1 Protein Catalog Number: ATGP0780

    Recombinant Human TNIP1 Protein Catalog Number: ATGP0780

    Recombinant human TNIP1 protein Catalog Number: ATGP0780 PRODUCT INPORMATION Expression system E.coli Domain 94-530aa UniProt No. Q15025 NCBI Accession No. NP_006049 Alternative Names TNFAIP3 interacting protein 1, ABIN-1, NAF1, VAN, Nip40-1 PRODUCT SPECIFICATION Molecular Weight 51.8 kDa (458aa) confirmed by MALDI-TOF Concentration 0.25mg/ml (determined by Bradford assay) Formulation Liquid in. 20mM Tris-HCl buffer (pH 7.5) containing 20% glycerol, 5mM DTT, 200mM NaCl Purity > 75% by SDS-PAGE Tag His-Tag Application SDS-PAGE Storage Condition Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles. BACKGROUND Description TNIP1 (TNFAIP3-interacting protein 1) has been shown to interacts with zinc finger protein A20/TNFAIP3 and inhibits TNF-induced NF-kappa-B-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal. In addition, interacts with HIV-1 matrix protein and is packaged into virions and overexpression can inhibit viral replication. It may regulate matrix nuclear localization, both nuclear import of PIC (Preintegration complex) and export of GAG polyprotein and viral genomic RNA during virion production. Recombinant human TNIP1 protein, fused to His-tag at N-terminus, was expressed in E. coli and purified by using 1 Recombinant human TNIP1 protein Catalog Number: ATGP0780 conventional chromatography techniques. Amino acid Sequence MGSSHHHHHH SSGLVPRGSH MSNVTASPTA PACPSDKPAP VQKPPSSGTS SEFEVVTPEE QNSPESSSHA NAMALGPLPR EDGNLMLHLQ RLETTLSVCA EEPDHGQLFT HLGRMALEFN RLASKVHKNE QRTSILQTLC EQLRKENEAL KAKLDKGLEQ RDQAAERLRE ENLELKKLLM SNGNKEGASG RPGSPKMEGT GKKAVAGQQQ ASVTAGKVPE VVALGAAEKK VKMLEQQRSE LLEVNKQWDQ HFRSMKQQYE QKITELRQKL ADLQKQVTDL EAEREQKQRD FDRKLLLAKS KIEMEETDKE QLTAEAKELR QKVKYLQDQL SPLTRQREYQ EKEIQRLNKA LEEALSIQTP PSSPPTAFGS PEGAGALLRK QELVTQNELL KQQVKIFEED FQRERSDRER MNEEKEELKK QVEKLQAQVT LSNAQLKAFK DEEKAREALR QQKRKAKA General References He CF., et al.
  • Newly Identified Gon4l/Udu-Interacting Proteins

    Newly Identified Gon4l/Udu-Interacting Proteins

    www.nature.com/scientificreports OPEN Newly identifed Gon4l/ Udu‑interacting proteins implicate novel functions Su‑Mei Tsai1, Kuo‑Chang Chu1 & Yun‑Jin Jiang1,2,3,4,5* Mutations of the Gon4l/udu gene in diferent organisms give rise to diverse phenotypes. Although the efects of Gon4l/Udu in transcriptional regulation have been demonstrated, they cannot solely explain the observed characteristics among species. To further understand the function of Gon4l/Udu, we used yeast two‑hybrid (Y2H) screening to identify interacting proteins in zebrafsh and mouse systems, confrmed the interactions by co‑immunoprecipitation assay, and found four novel Gon4l‑interacting proteins: BRCA1 associated protein‑1 (Bap1), DNA methyltransferase 1 (Dnmt1), Tho complex 1 (Thoc1, also known as Tho1 or HPR1), and Cryptochrome circadian regulator 3a (Cry3a). Furthermore, all known Gon4l/Udu‑interacting proteins—as found in this study, in previous reports, and in online resources—were investigated by Phenotype Enrichment Analysis. The most enriched phenotypes identifed include increased embryonic tissue cell apoptosis, embryonic lethality, increased T cell derived lymphoma incidence, decreased cell proliferation, chromosome instability, and abnormal dopamine level, characteristics that largely resemble those observed in reported Gon4l/udu mutant animals. Similar to the expression pattern of udu, those of bap1, dnmt1, thoc1, and cry3a are also found in the brain region and other tissues. Thus, these fndings indicate novel mechanisms of Gon4l/ Udu in regulating CpG methylation, histone expression/modifcation, DNA repair/genomic stability, and RNA binding/processing/export. Gon4l is a nuclear protein conserved among species. Animal models from invertebrates to vertebrates have shown that the protein Gon4-like (Gon4l) is essential for regulating cell proliferation and diferentiation.
  • Cep-2020-00633.Pdf

    Cep-2020-00633.Pdf

    Clin Exp Pediatr Vol. 64, No. 5, 208–222, 2021 Review article CEP https://doi.org/10.3345/cep.2020.00633 Understanding the genetics of systemic lupus erythematosus using Bayesian statistics and gene network analysis Seoung Wan Nam, MD, PhD1,*, Kwang Seob Lee, MD2,*, Jae Won Yang, MD, PhD3,*, Younhee Ko, PhD4, Michael Eisenhut, MD, FRCP, FRCPCH, DTM&H5, Keum Hwa Lee, MD, MS6,7,8, Jae Il Shin, MD, PhD6,7,8, Andreas Kronbichler, MD, PhD9 1Department of Rheumatology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea; 2Severance Hospital, Yonsei University College of Medicine, Seoul, Korea; 3Department of Nephrology, Yonsei University Wonju College of Medicine, Wonju, Korea; 4Division of Biomedical Engineering, Hankuk University of Foreign Studies, Yongin, Korea; 5Department of Pediatrics, Luton & Dunstable University Hospital NHS Foundation Trust, Luton, UK; 6Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea; 7Division of Pediatric Nephrology, Severance Children’s Hospital, Seoul, Korea; 8Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, Korea; 9Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria 1,3) The publication of genetic epidemiology meta-analyses has analyses have redundant duplicate topics and many errors. increased rapidly, but it has been suggested that many of the Although there has been an impressive increase in meta-analyses statistically significant results are false positive. In addition, from China, particularly those on genetic associa tions, most most such meta-analyses have been redundant, duplicate, and claimed candidate gene associations are likely false-positives, erroneous, leading to research waste. In addition, since most suggesting an urgent global need to incorporate genome-wide claimed candidate gene associations were false-positives, cor- data and state-of-the art statistical inferences to avoid a flood of rectly interpreting the published results is important.
  • Research Article Altered AKT1 and MAPK1 Gene

    Research Article Altered AKT1 and MAPK1 Gene

    Hindawi Publishing Corporation Mediators of Inflammation Volume 2012, Article ID 495934, 14 pages doi:10.1155/2012/495934 Research Article Altered AKT1 and MAPK1 Gene Expression on Peripheral Blood Mononuclear Cells and Correlation with T-Helper-Transcription Factors in Systemic Lupus Erythematosus Patients Sonia Garcia-Rodriguez,1 Jose-Luis Callejas-Rubio,2 Norberto Ortego-Centeno,2 Esther Zumaquero,1, 3 Raquel Rıos-Fernandez,´ 2 Salvador Arias-Santiago,4 Pilar Navarro,1 Jaime Sancho,1 and Mercedes Zubiaur1 1 Department of Cellular Biology and Immunology, Instituto de Parasitolog´ıa y Biomedicina Lopez-Neyra,´ (IPBLN-CSIC), Parque Tecnologico´ Ciencias de la Salud, Avenida Conocimiento s/n, Armilla, 18100 Granada, Spain 2 Systemic Autoimmune Diseases Unit, Department of Internal Medicine, San Cecilio University Hospital (SCUH), Avenida Dr. Oloriz, no. 16, Granada 18012, Spain 3 Department of Microbiology, University of Alabama at Birmingham, 1720 2nd Ave South, Birmingham, AL 35294, USA 4 Department of Dermatology, SCUH, Avenida Dr. Oloriz, No. 16, Granada 18012, Spain Correspondence should be addressed to Mercedes Zubiaur, [email protected] Received 9 May 2012; Revised 21 August 2012; Accepted 3 September 2012 Academic Editor: Eric F. Morand Copyright © 2012 Sonia Garcia-Rodriguez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Kinases have been implicated in the immunopathological mechanisms of Systemic Lupus Erythematosus (SLE). v-akt murine- thymoma viral-oncogene-homolog 1 (AKT1) and mitogen-activated-protein-kinase 1 (MAPK1) gene expressions in peripheral mononuclear cells from thirteen SLE patients with inactive or mild disease were evaluated using quantitative real-time reverse- transcription polymerase-chain-reaction and analyzed whether there was any correlation with T-helper (Th) transcription factors (TF) gene expression, cytokines, and S100A8/S100A9-(Calprotectin).
  • Anti-TNIP1 (Aa 606-636) Polyclonal Antibody (DPABH-24770) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use

    Anti-TNIP1 (Aa 606-636) Polyclonal Antibody (DPABH-24770) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use

    Anti-TNIP1 (aa 606-636) polyclonal antibody (DPABH-24770) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION Antigen Description Interacts with zinc finger protein A20/TNFAIP3 and inhibits TNF-induced NF-kappa-B-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal (By similarity). Increases cell surface CD4(T4) antigen expression. Interacts with HIV-1 matrix protein and is packaged into virions and overexpression can inhibit viral replication. May regulate matrix nuclear localization, both nuclear import of PIC (Preintegration complex) and export of GAG polyprotein and viral genomic RNA during virion production. Immunogen Synthetic peptide conjugated to KLH, corresponding to a region within C terminal amino acids 606-636 of Human TNIP1 (NP_006049.3). Isotype IgG Source/Host Rabbit Species Reactivity Human Purification Immunogen affinity purified Conjugate Unconjugated Applications WB Format Liquid Size 100 μg Buffer Constituent: 99% PBS Preservative 0.09% Sodium Azide Storage Store at 2-8°C for up to 6 months. For long term storage store at -20°C. GENE INFORMATION Gene Name TNIP1 TNFAIP3 interacting protein 1 [ Homo sapiens ] Official Symbol TNIP1 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 1 © Creative Diagnostics All Rights Reserved Synonyms TNIP1; TNFAIP3 interacting protein 1; TNFAIP3-interacting protein 1; ABIN 1; KIAA0113; NAF1; Nef associated factor 1 SNP; VAN; virion associated nuclear shuttling protein; Nef-associated factor 1 SNP; HIV-1 Nef-interacting protein; virion-associated nuclear shuttling protein; ABIN-1; nip40-1; Entrez Gene ID 10318 Protein Refseq NP_001239314 UniProt ID B7Z8K2 Chromosome Location 5q32-q33.1 Pathway EGFR1 Signaling Pathway; TNF-alpha/NF-kB Signaling Pathway; Function protein binding; 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 2 © Creative Diagnostics All Rights Reserved.
  • Association Between TNIP1, MPHOSPH6 and ZNF208 Genetic Polymorphisms and the Coronary Artery Disease Risk in Chinese Han Population

    Association Between TNIP1, MPHOSPH6 and ZNF208 Genetic Polymorphisms and the Coronary Artery Disease Risk in Chinese Han Population

    www.impactjournals.com/oncotarget/ Oncotarget, Advance Publications 2017 Association between TNIP1, MPHOSPH6 and ZNF208 genetic polymorphisms and the coronary artery disease risk in Chinese Han population Yanbin Song1,2,3, Mengdan Yan1,2, Jing Li1,2, Jingjie Li1,2, Tianbo Jin1,2 and Chao Chen1,2 1Key Laboratory of Resource Biology and Biotechnology in Western China (Northwest University), Ministry of Education, Xi’an, Shaanxi 710069, China 2School of Life Sciences, Northwest University, Xi’an, Shaanxi 710069, China 3Department of Cardiovascular, Yanan University Affiliated Hospital, Yanan, Shaanxi 716000, China Correspondence to: Tianbo Jin, email: [email protected] Chao Chen, email: [email protected] Keywords: coronary artery disease (CAD), polymorphisms, ZNF208, TNIP1, MPHOSPH6 Received: May 18, 2017 Accepted: June 24, 2017 Published: August 24, 2017 Copyright: Song et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Introduction: Coronary artery disease (CAD) is a common disease and among the leading cause of death in the general population. Inherited factors are involved in the pathogenesis of CAD. Aims: Our study examined whether SNPs in TNIP1, MPHOSPH6, ZNF208 to be associated with CAD risk in a Chinese Han population. We recruited 596 CAD patients, 603 controls and genotyping fifteen SNPs using Sequenom MassARRAY. For association analysis between TNIP1, MPHOSPH6 and ZNF208 and CAD was determined by Odds ratios (ORs) with 95% confidence intervals (CIs) using Logistic Regression. Results: The results indicated in allel model, the rs960709 in TNIP1 was associated with CAD risk (OR = 0.78, 95%CI = 0.65-0.94, P=0.010).